Detalles de la búsqueda
1.
Impact of distinct cognitive domains on gait variability in individuals with mild cognitive impairment and dementia.
Exp Brain Res
; 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38753043
2.
Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies.
JAMA
; 331(15): 1298-1306, 2024 04 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38506839
3.
Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study.
Mult Scler
; 29(14): 1795-1807, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37905526
4.
The moderating roles of self-efficacy and depression in dual-task walking in multiple sclerosis: A test of self-awareness theory.
J Int Neuropsychol Soc
; 29(3): 274-282, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35465869
5.
Diroximel fumarate (DRF) in patients with relapsing-remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study.
Mult Scler
; 26(13): 1729-1739, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31680631
6.
The association between MRI brain volumes and computerized cognitive scores of people with multiple sclerosis.
Brain Cogn
; 145: 105614, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32927305
7.
Safety and efficacy of ADS-5102 (amantadine) extended release capsules to improve walking in multiple sclerosis: A randomized, placebo-controlled, phase 2 trial.
Mult Scler
; 25(4): 601-609, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29368539
8.
Computerized neuropsychological assessment devices in multiple sclerosis: A systematic review.
Mult Scler
; 25(14): 1848-1869, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31637963
9.
The impact of subjective cognitive fatigue and depression on cognitive function in patients with multiple sclerosis.
Mult Scler
; 24(2): 196-204, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28273778
10.
Best Practices for Intrathecal Baclofen Therapy: Screening Test.
Neuromodulation
; 19(6): 616-22, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27434115
11.
Multiple Sclerosis, Fatigue, Expanded Disability Status Scale: A Cross-Sectional Exploration of Sleep Efficiency and Quantitative Sleep Parameters.
Int J MS Care
; 26(2): 57-60, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38482517
12.
Peering further into the mind's eye: combining visual evoked potential and optical coherence tomography measures enhances insight into the variance in cognitive functioning in multiple sclerosis.
J Neurol
; 271(2): 658-673, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38091086
13.
Thalamic atrophy and dysconnectivity are associated with cognitive impairment in a multi-center, clinical routine, real-word study of people with relapsing-remitting multiple sclerosis.
Neuroimage Clin
; 42: 103609, 2024 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38718640
14.
Characterizing the 'feel-good experience' in multiple sclerosis patients treated with natalizumab or other therapies.
Neurodegener Dis Manag
; 13(1): 23-34, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36285716
15.
Humoral immune response after Ad26.COV2.S vaccination in patients with multiple sclerosis treated with natalizumab.
Mult Scler J Exp Transl Clin
; 9(4): 20552173231218117, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38089563
16.
Cognitive impairment in people with multiple sclerosis: Perception vs. performance - factors that drive perception of impairment differ for patients and clinicians.
Mult Scler Relat Disord
; 69: 104410, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36399966
17.
Cognitive impairment, fatigue and depression in multiple sclerosis: Is there a difference between benign and non-benign MS?
Mult Scler Relat Disord
; 73: 104630, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36965219
18.
Multiple sclerosis and quality of life: The role of cognitive impairment on quality of life in people with multiple sclerosis.
Mult Scler Relat Disord
; 79: 104966, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37690436
19.
Health-Related Quality of Life with Diroximel Fumarate in Patients with Relapsing Forms of Multiple Sclerosis: Findings from Qualitative Research Using Patient Interviews.
Adv Ther
; 39(7): 3199-3213, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35556227
20.
Dimethyl fumarate is associated with lower rates of infection and lower infection-related healthcare costs when compared with ocrelizumab.
Mult Scler Relat Disord
; 63: 103921, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35700674